Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients.

Thokala, P. orcid.org/0000-0003-4122-2366, Arrowsmith, M., Poku, E. orcid.org/0000-0001-6549-5081 et al. (5 more authors) (2016) Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients. Journal of Infection Prevention, 17 (5). pp. 216-223. ISSN 1757-1774

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: Tegaderm chlorhexidine gluconate (CHG); adult critical care; arterial catheters; bloodstream infection; catheter-related bloodstream infection (CRBSI); central venous catheter (CVC); chlorhexidine dressing; cost model; cost-effectiveness; vascular access
Dates:
  • Published: 13 July 2016
  • Accepted: 28 May 2016
  • Published (online): 13 July 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 07 Sep 2016 09:18
Last Modified: 07 Sep 2016 09:18
Published Version: http://dx.doi.org/10.1177/1757177416657162
Status: Published
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/1757177416657162
Related URLs:

Share / Export

Statistics